Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 36031390.
- Also identified by DOI 10.1093/cid/ciac695 and PMC identifier 10169385.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We followed 54 infants with in utero HIV after initiating very early antiretroviral treatment. At weeks 24 and 48, ≥80% had CD4 ≥1500 cells/mm3 and CD4% ≥25%. Routine Pneumocystis jirovecii pneumonia prophylaxis in the first year of life may not be necessary for all very early treated infants. NCT02140255.
Medical subject headings
- HIV Infections
- Pneumonia, Pneumocystis
- Anti-HIV Agents
- Pneumocystis carinii